Skip to content

Author

B. Dell'Osso

We have 6 of 659 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Impulsivity is the principal correlate of problematic internet use in young adults with attention-deficit/hyperactivity disorder: a cross-sectional clinical study

Introduction Attention-deficit/hyperactivity disorder (ADHD) and problematic internet use share clinical features such as impulsivity, emotional dysregulation and impaired inhibitory control, but most evidence comes from children, adolescents and non-clinical samples. It remains unclear which dimension carries this ass...

Luca Giacovelli, Davide Fedeli, V. Martiadis et al. · 0 citations
Sep 2026

Use of risperidone in-situ microparticles in real world: patterns of prescription and dose selection in patients with psychotic disorders.

Long-acting injectable (LAI) antipsychotics are important for improving adherence and preventing relapse. Risperidone in-situ microparticles (ISM), a once monthly LAI using ISM technology, rapidly achieves therapeutic plasma levels without loading doses or oral supplementation. Real-world evidence on its use remains li...

I. Di Bernardo, Paolo Brambilla, D'Agostino Armando et al. · 0 citations
Open access Oct 2026

ADHD Presentations and Severity in Adults: Psychometric Profiles, Psychiatric Comorbidities, and Emotional Dysregulation in Relation to Psychiatric Hospitalization

The findings of this retrospective, cross-sectional study support the clinical relevance of assessing ADHD presentation, severity, and emotional dysregulation, and generate hypotheses that require confirmation in prospective, multicentre studies.

M. Olivola, Paola Landi, V. Martiadis et al. · 0 citations
Review Open access Sep 2026

Psilocybin and ayahuasca in treatment-resistant depression: clinical evidence, methodological constraints and ethical challenges: a narrative review

Background Treatment-resistant depression (TRD) is a major clinical challenge, with many patients failing to respond to conventional antidepressants. Psychedelic compounds such as psilocybin and ayahuasca have recently gained attention as potential rapid-acting therapies. Beyond their neurobiological effects, methodolo...

S. C. Civardi, F. Besana, F. Durbano et al. · 0 citations
Review Open access Oct 2026

Beyond Genotype: Integrating Phenoconversion into Pharmacogenetic Decision-Making in Psychiatry

Interindividual variability in psychotropic drug response contributes to treatment failure, adverse drug reactions, and repeated medication adjustments. Pharmacogenetics supports precision prescribing by identifying genetic variants associated with drug metabolism, efficacy, and tolerability, and evidence-based recomme...

T. Prodi, M. G. Nielsen, Floriana De Cillis et al. · 0 citations
Open access Sep 2026

From real-world experience to precision prescribing of antidepressants: a machine-learning analysis of clinicians' treatment choices.

This study examined whether psychiatrists' routine prescribing decisions could be used to identify practice-grounded patterns supporting precision-oriented treatment selection, and found that similarity-based models may provide a more conceptually coherent approach.

Francesco Calabró, Claudio Caiazza, U. Albert et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.